Format

Send to

Choose Destination
Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00306-16. doi: 10.1128/CVI.00306-16. Print 2017 Jan.

Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Author information

1
Department of Pathology & Laboratory Medicine, Medical School, University of Texas, Houston, Texas, USA.
2
Centers for Disease Control and Prevention, Division of Vector-Borne Disease, Fort Collins, Colorado, USA.
3
Institute of Experimental Immunology, Euroimmun AG, Lübeck, Germany.
4
Institute of Experimental Immunology, Euroimmun AG, Lübeck, Germany l.komorowski@euroimmun.de.

Abstract

Lyme borreliosis is caused by tick-transmitted spirochetes of the Borrelia burgdorferi sensu lato group and is the most common vector-borne disease in the United States and Europe. Outer surface protein C (OspC) is a 23-kDa outer surface lipoprotein expressed during spirochete transmission from the tick to the vertebrate host. In a previous study, we found that immunization with a recombinant disulfide-bridged dimeric form of OspC (D-OspC) stimulates increased antibody responses relative to immunization with commonly employed monomeric OspC. Here, we report that mice immunized with dimeric OspC proteins also exhibited enhanced protection against infection with the cognate B. burgdorferi strain. Mice were protected by four immunizations containing as little as 100 ng of dimeric OspC, suggesting that this form of the protein can induce protective immunity within a dose range reasonable for a human or veterinary vaccine. In contrast, monomeric OspC was only partially protective at much higher doses. IgG subclass analysis revealed that D-OspC-immunized animals mainly possessed anti-OspC-IgG1. In contrast, infected animals develop anti-OspC restricted to the IgG3 isotype. A subset of antibodies generated by dimeric OspC immunization did not recognize the monomeric variant, indicating that unique epitopes exist on the dimeric form. Moreover, monoclonal antibodies that recognized only dimeric OspC protected mice from B. burgdorferi challenge, whereas another monoclonal that recognized both immunogens was not protective. These studies suggest that this dimeric OspC presents distinctive epitopes that generate antibodies protective against B. burgdorferi infection and could be a useful vaccine component.

KEYWORDS:

Borrelia; Borrelia burgdorferi; ELISA; Lyme disease; OspC; immunoblot; vaccine

PMID:
27733423
PMCID:
PMC5216437
DOI:
10.1128/CVI.00306-16
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center